Novo Integrated Sciences (NVOS) 10-K2023 FY Annual report

Filed: 14 Dec 23, 5:01pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: affirmative, al, Alsbrook, authenticated, BCF, bifurcation, Blacksheep, Blake, bookkeeping, Brampton, CA, check, clawback, Coe, cognitive, conventional, custody, defect, descent, diminution, embedded, encumbered, enlargement, erroneously, evidenced, extinguished, feature, forfeited, forfeiture, gel, Gemological, inconsistency, India, inspect, inspection, intrinsic, JPRx, Kenya, lapse, left, Ludhiana, merger, metabolism, MH, monetization, nonqualified, numerical, Ocean, omission, Ophir, payroll, plenary, priority, Punjab, quorum, Receivership, reorganization, repatriate, repatriated, repurchase, RSU, SAR, sentence, Sethi, skin, spring, strike, sunset, surrender, tandem, Terrence, thereat, thereon, Thermal, thirty, Turkey, uncorrected, unfettered, unregistered, unrestricted, unsellable, uptake, VAP, Vik, Vivek, Wave, welfare

Removed: actively, amending, APK, Avenue, binder, capitalization, comparison, confirmation, crop, deliverable, documented, elite, engineering, entirety, faith, field, finalize, fourth, FTE, hardware, Heart, HGF, initiating, insurable, irrevocably, layout, lockdown, Maxim, maximizing, observation, offshore, onset, outdoor, proposal, reliance, residing, restructure, Roosevelt, Simplifying, subscription, subsidy, tentatively, text, wage

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

NVOS similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statements on Form S-1 (File No. 333-267401), Form S-3 (File No. 333-264360, File No. 333-256892, and File No. 333-254278), and Form S-8 (File No. 333-253289 and File No. 333-22686) of our audit report dated December 14, 2023, with respect to the consolidated balance sheet of Novo Integrated Sciences, Inc. and its subsidiaries as of August 31, 2023, and the related consolidated statement of operations and comprehensive loss, consolidated statement of stockholders’ equity, and consolidated statement of cash flows for the year then ended. Our report relating to those financial statements includes an emphasis of matter paragraph regarding substantial doubt as to the Company’s ability to continue as a going concern.

Spokane, Washington

December 14, 2023

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.